Junction: Myasthenia Gravis


People With Rare Diseases Report Facing Stigma, Poor Quality of Life

People with rare diseases who live in the United States have a poor health-related quality of life and experience significant stigma, according to a study published in the Orphanet Journal of Rare Diseases. A rare disease in the United States can be defined as any disease in which the prevalence is less than 200,000 cases.…

clinical trial research

Phase 3 Myasthenia Gravis Trials Yield Positive Results for 2 Potential Therapies

Positive results from 2 phase 3 clinical trials of potential generalized myasthenia gravis (gMG) therapies were recently presented as posters at the 14th Myasthenia Gravis Foundation of America (MGFA) International Conference on Myasthenia and Related Disorders. The 2 therapies, zilucoplan and rozanolixizumab, were both associated with improvements in Myasthenia Gravis Activities of Daily Living (MG-ADL)…

online questionnaire

Quality of Life Questionnaire Recommended When Treating Myasthenia Gravis

Researchers studying the accuracy of quality of life (QoL) scales in patients with myasthenia gravis recommended their use in clinical practice because some symptoms of the disease can be difficult to examine, according to a study published in the Journal of Clinical Medicine.  Myasthenia gravis is an autoimmune disease in which the neuromuscular junction is…

dna sequencing

Case Studies Suggest Etiopathogenetic Link Between NMOSD and Myasthenia Gravis

Two cases of coexisting neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG) suggest a possible etiopathogenetic link between the diseases, reports a study published in Multiple Sclerosis and Related Disorders. Using next-generation sequencing (NGS), 2 mutant human leukocyte antigen (HLA) alleles were found in common between the 2 patients—HLA-DQA1*05:01:01 and HLA-DPB1*04:02:01. “To summarize, although…

covid vaccines

Benefits of COVID-19 Vaccine Outweigh the Risks in MG, Study Suggests

Researchers assessing the safety of vaccines for patients with myasthenia gravis (MG) found that some of them, such as the anti-SARS-CoV-2, may cause MG exacerbations, but evidence points overwhelmingly in favor that they are still recommended for these patients, as published in the Journal of Neurology. MG, a chronic autoimmune disease affecting the neuromuscular junction,…


Lymphoplasma Exchange Effective in Some Myasthenia Gravis Cases

Lymphoplasma exchange is an effective treatment for patients with myasthenia gravis who are in a state of exacerbation or in preparation for a thymectomy, according to a new retrospective study performed in a Chinese center. According to the authors of the study, published in Frontiers in Immunology, the early use of lymphoplasma exchange on early-onset…

Next post in MG Features